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Abstract Theaimofthisstudywastocomparetheresultsof
the day-to-day self-evaluation of sleep quality by sleep logs
with Parkinson’s disease sleep scale (PDSS) in Parkinson’s
disease(PD)patients.Actigraphywasusedasanindependent
analysisofnighttimeactivityinterferingwithsleep.Atotalof
71idiopathicPDpatientsand21age-andsex-matchednormal
individuals lacking any type of sleep disturbance were
recruited. Sleep was evaluated by PDSS, 7-d sleep log and
actigraphy. Sleep logs and PDSS showed reduced sleep
quality and daytime somnolence scores in moderate/severe
PD patients as compared to healthy controls. Signiﬁcant cor-
relations were found between sleep quality in sleep logs and
all domains of PDSS sleep quality, except for the presence of
nocturia,whichcorrelatedwithnocturnalactivity.PDseverity
and depression were the only predictors of reduced sleep
quality. The retrospective and day-to-day sleep self-evalua-
tions were coincident. Reduced sleep quality was related to
increased PD severity and depression scores.
Keywords Sleep logs  Parkinson’s disease  Actigraphy 
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Introduction
Up to 90% of Parkinson’s disease (PD) patients complain
of sleep problems [11, 14, 24]. The most commonly
observed sleep disorders in PD patients are linked to noc-
turnal motor disorder, including off-state dystonia, cramps,
tremor, or severe akinesia and rigidity producing painful
postures and problems when turning in bed as well as
neuropsychiatric symptoms, i.e., vivid dreams, nocturnal
hallucinations, and REM sleep behavior disorder [3, 6, 12].
Periodic limb movements disorder and nocturia are also
commonly observed in PD [3, 7, 12].
The 15-item Parkinson’s disease sleep scale (PDSS) has
been developed for retrospective sleep self-evaluation in
PD [3, 17]. The scale is reliable, is able to differentiate
healthy controls from PD patients, and correlates well with
disease severity. The daytime somnolence item (#15) and
restlessness item (#4) have received support from the Ep-
worth score [3] and International Restless Legs Syndrome
Study Group diagnostic criteria [25], respectively. One of
its limitations is that it is based on 15-d retrospective sleep
quality self-evaluation.
On the other hand, sleep logs allow a day-to-day eval-
uation of bedtime, rising time, sleep latency, number and
duration of awakenings, naps, and some indexes of sleep
quality [23]. Though sleep logs are widely used for sleep
evaluation in healthy subjects and insomniacs [4, 21, 23],
they have not been systematically assessed in PD.
In the present study, the day-to-day sleep quality self-
evaluation by sleep log was compared to PDSS results.
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Methods
Study sample
PD patients were recruited from a tertiary out-patient
clinic. To be included, subjects had to fulﬁll the United
Kingdom Parkinson’s Disease Society Brain Bank criteria
[16] and have a mini-mental state examination (MMSE)
score[24 points.
A group of healthy controls frequency-matched for sex
and age, without sleep complaints, chronic diseases or
secondary causes of insomnia, and not taking any type of
hypnotic medication, were recruited from the general
population. The protocol conforms to the principles enu-
merated in the Helsinki Declaration, was approved by the
Institutional Review Board, and all subjects signed an
informed consent after full explanation of the procedures.
PD evaluation
PD patients were subjected to cognitive, psychiatric, and
motor evaluation including the MMSE [10], Montgomery-
Asberg Depression Rating scale (MADRS) [20], Uniﬁed
PD rating scale (UPDRS) [9], and Hoehn & Yahr scale
(H&Y) [15]. Medication records were used to calculated
levodopa equivalent daily dose (LDED) according to the
usual formula [22].
PDSS
PD patients and healthy controls completed the self-
administered Spanish version of PDSS during their clinical
interviews [17]. For evaluation of the results, PDSS items
were grouped according to domain: sleep quality (items 1–
3); nocturnal restlessness (items 4 and 5); nocturnal psy-
chosis (items 6 and 7), nocturia (item 8); nocturnal motor
symptoms (items 9–13) and daytime somnolence (items 14
and 15) [25].
Sleep diary and actigraphy
After the initial clinical interview, a standard sleep log was
completed by patients and controls every day after waking
up. Information about the time at which subjects fell asleep
and woke up, as well as the number and duration of per-
ceived awakenings were registered [1, 2]. It also included
three 10 cm visual analog scales for quantiﬁcation of sleep
latency (‘‘a lot’’–‘‘a little’’), sleep quality (‘‘bad’’–‘‘good’’)
and morning freshness (i.e., how tired the subject felt on
waking, ‘‘a lot’’–‘‘a little’’). Total sleep log scores were
calculated as the sum of all three items, ranging between 0
and 30.
Participants were instructed to wear an actigraphy
device (MicroMini-Motionlogger, Ambulatory Monitoring
Inc, NY, USA) in addition to completing the 7-d sleep log.
The actigraphic device was attached to the non-dominant
wrist [18]. Nocturnal activity, nocturnal motility time, and
time in bed were calculated using Action W 2.5 software
(Ambulatory Monitoring Inc, NY, USA).
Statistical analysis
Categorical data were compared using chi-square, and
numerical variables by ANOVA. Factor analysis was used
to check the reliability of the sleep logs. The Pearson
correlation coefﬁcient was employed to assess the associ-
ations between PDSS, sleep log, and actigraphy.
Sleep log scores and nocturnal activity were related to
the characteristics of PD and its treatment by multiple
linear regression.
Actigraphic data were log transformed to render them
normally distributed. Data are expressed as mean ± stan-
dard error of the mean unless otherwise stated. Alfa error
was set at 0.05.
Results
A total of 71 PD patients and 25 age- and sex-matched
controls were recruited. Four controls were excluded
because of incomplete data. Age was 64.4 ± 2.0 years in
controls and 68.5 ± 1.0 years in PD patients (p = 0.1). No
gender differences were noticed between controls and
patients (29 and 49% were males, respectively, p = 0.1).
PD patients showed UPDRS II scores (daily living), III
(motor score), and IV (levodopa complication scores) of
11.4 ± 0.8, 17.8 ± 1.2, 2.9 ± 0.5, respectively. The sum
of these scores (UPDRS II–IV) was 32.0 ± 1.9. Median
Hoehn & Yahr score was 2 (interquartile range 1.5–3).
Mean disease duration was 7.7 ± 0.7 years and mean
MMSE and MADRS scores were 29.1 ± 0.2 and
7.0 ± 0.8, respectively. Out of the 71 PD patients, 14 were
medication-naı ¨ve (20%). In treated subjects, mean LDED
was 596.9 ± 54.9 mg/d. Fifteen (21%) patients received
only levodopa, while 14 (20%), 13 (18%), 10 (14%), and 5
(7%) patients received also piribedil, cabergoline, pram-
ipexol, or other dopaminergic agonists, respectively.
Sleep evaluation in PD patients
As summarized in Table 1, sleep quality was signiﬁcantly
worse in PD patients as compared to controls when
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123evaluated either by PDSS or by sleep log. While advanced
PD patients (H&Y III–V) showed striking sleep distur-
bance, mild/moderate PD patients (H&Y I–II) showed less
sleep deterioration, reaching signiﬁcance only in PDSS
sleep quality, daytime somnolence, and PDSS total score.
Comparison of historical sleep data provided by PDSS
with day-to-day assessment by sleep log and actigraphy
Signiﬁcant correlations between PDSS and sleep log were
found (Table 2). As can be seen, in general, sleep log
quality scores correlated with all PDSS subdomains, except
for Nocturia, which correlated only with increased awak-
ening numbers, reduced morning alertness, and higher
nocturnal activity.
The internal consistency of sleep logs sleep quality
indicators were evaluated by factor analysis. Only one
factor including sleep latency, sleep quality, and morning
alertness, explaining 60% of total variance, could be found.
A multiple regression analysis showed that, on one
hand, sleep log total score was independently related to
H&Y score (r =- 0.25, p = 0.05) and MADRS score
(r =- 0.24, p = 0.05). On the other hand, nocturnal
activity correlated with LDED (r =- 0.40, p = 0.02) and
MMSE score (r =- 0.25, p = 0.05).
Discussion
In the present study, day-to-day sleep assessment by sleep
logs was compared to PDSS retrospective sleep evaluation.
The foregoing results indicate that daily evaluations of
sleep quality by sleep log correlated signiﬁcantly with most
PDSS subdomains, suggesting that both tools can evaluate
sleep quality to a similar extent. Moreover, sleep quality
evaluated by sleep logs was related to disease severity and
depression in PD, which coincides with previous reports [3,
11, 25].
The main limitation of this study is that polysomnog-
raphy (PSG) was not used as the reference method for
sleep evaluation. Nonetheless, the signiﬁcant divergence
between PSG and subjective sleep evaluation observed in
PD [13] as well as the result that subjective more than
objective ﬁndings of impaired sleep quality impact nega-
tively on quality of life [19] suggest that PSG may not be
the best method against which subjective sleep evaluation
tools should be compared.
Many questions on the sleep log and PDSS are similar,
providing the basis for the results herein observed. None-
theless, while the PDSS retrospectively assesses sleep
quality in 15 days constituting a simple bedside screening
of sleep disturbances in PD, the degree of detail provided
Table 1 Comparison of sleep log and actigraphic data between PD patients and controls
Controls (n = 21) H&Y I–II (n = 46) H&Y III–V (n = 25) p
PDSS
Sleep quality 22.69 ± 1.09 19.8 ± 0.85* 18.46 ± 1.23* 0.05
Nocturnal restlessness 16.43 ± 0.42 15.8 ± 0.45 14.83 ± 0.72 0.2
Nocturnal psychosis 17.81 ± 0.5 16.27 ± 0.48 14.24 ± 0.84* 0.002
a
Nocturia 4.69 ± 0.71 3.74 ± 0.49 4.55 ± 0.7 0.5
Nocturnal motor symptoms 44.65 ± 0.66 42.02 ± 0.93 38.37 ± 1.72* \0.01
a
Daytime somnolence 16.51 ± 0.37 14.13 ± 0.6* 11.99 ± 0.93* \0.001
a
PDSS total score 122.78 ± 1.77 111.78 ± 2.38* 102.43 ± 3.71* \0.001
a
Sleep log
Sleep latency 1.93 ± 0.39 1.99 ± 0.21 2.22 ± 0.28 0.8
Sleep quality 7.5 ± 0.37 6.87 ± 0.25 5.89 ± 0.23* 0.003
a
Morning alertness 7.29 ± 0.43 6.99 ± 0.24 6.15 ± 0.38 0.08
Total sleep log score 22.41 ± 0.91 21.86 ± 0.56 19.82 ± 0.56* 0.03
Awakenings number 1.31 ± 0.24 1.57 ± 0.14 1.82 ± 0.14 0.2
Awakening time (min) 19.75 ± 4.66 26.14 ± 4.47 38.92 ± 6.73 0.8
Nap time (min) 20.29 ± 7.06 34.71 ± 4.54 47.3 ± 6.69* 0.02
Actigraphy
Nocturnal activity (counts) 732.53 ± 76.73 887.41 ± 77.53 1029.64 ± 179.53 0.5
Nocturnal motility time (min) 30.69 ± 4.77 35.3 ± 3.56 38.47 ± 6.9 0.6
Time in bed (min) 458.34 ± 15.73 421.67 ± 8.33 415.12 ± 11.71 0.04
PDSS total score is the sum of all its domains. Sleep log total score is obtained as: sleep quality ? morning alertness ? (10 - sleep latency)
* p\0.05 versus controls (ANOVA followed by Dunnett’s post-hoc test)
a Brown–Forsythe adjustment for unequal variances was employed
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123by the sleep logs make them suitable for analysis of par-
ticular cases or for clinical interventional studies.
Actigraphy is a common companion to the sleep log [4,
21, 23]. Its use in PD sleep studies [5, 8] has been ques-
tioned mainly because it may not be accurate enough to
discern sleep state from PD-related immobility or tremor
[12], which was conﬁrmed in our study.
In summary, retrospective sleep quality evaluation by
the PDSS and day-to-day evaluation by sleep log coin-
cided. While PDSS can be used as a simple bedside sleep
disturbances screening tool, sleep logs are suitable for
analysis of particular cases or for clinical interventional
studies. On the other hand, while utility of actigraphy for
nocturnal activity measurement is warranted, its role in
sleep evaluation in PD appears to be very limited.
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